Reelin signalling in neuroblastoma: Migratory switch in metastatic stages

International Journal of Oncology

Volumn 41, Issue 2, 2012, Pages 681-689

  Becker, Jürgen ^a   Fröhlich, Johanna ^a   Perske, Christina ^a   Pavlakovic, Helena ^a   Wilting, Jörg ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Drosophila disabled homologue 1; LRP8; Lymphatics; Neuroblastoma; Reelin; Tumor endothelial cells; Very low density lipoprotein receptor

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 8; PROTEIN; REELIN; RETINOIC ACID; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; CANCER GRADING; CANCER STAGING; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; IN VITRO STUDY; LYMPH VESSEL ENDOTHELIUM; METASTASIS; NEURAL CREST; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL ADHESION MOLECULES, NEURONAL; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM NEOPLASMS; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LDL-RECEPTOR RELATED PROTEINS; LYMPHATIC METASTASIS; NERVE TISSUE PROTEINS; NEUROBLASTOMA; RECEPTORS, LDL; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION;

EID: 84863569425     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1488     Document Type: Article

References (54)

1. Castleberry RP: Neuroblastoma. Eur J Cancer 33: 1430-1438, 1997.
2. Maris JM: Recent advances in neuroblastoma. N Engl J Med 362: 2202-2211, 2010.
3. Maris JM, Hogarty MD, Bagatell R and Cohn SL: Neuroblastoma. Lancet 369: 2106-2120, 2007. (Pubitemid 46935947)
4. Brodeur GM: Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203-216, 2003.
5. Weinstein JL, Katzenstein HM and Cohn SL: Advances in the diagnosis and treatment of neuroblastoma. Oncologist 8: 278-292, 2003. (Pubitemid 36648814)
6. Westermann F and Schwab M: Genetic parameters of neuroblastomas. Cancer Lett 184: 127-147, 2002. (Pubitemid 34804499)
7. Becker J, Erdlenbruch B, Noskova I, et al: Keratoepithelin suppresses the progression of experimental human neuroblastomas. Cancer Res 66: 5314-5321, 2006. (Pubitemid 43844956)
8. Becker J, Pavlakovic H, Ludewig F, et al: Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2. Clin Cancer Res 16: 1431-1441, 2010.
9. Becker J, Volland S, Noskova I, Schramm A, Schweigerer LL and Wilting J: Keratoepithelin reverts the suppression of tissue factor pathway inhibitor 2 by MYCN in human neuroblastoma: a mechanism to inhibit invasion. Int J Oncol 32: 235-240, 2008. (Pubitemid 351176082)
10. Volland S, Kugler W, Schweigerer L, Wilting J and Becker J: Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma. Int J Cancer 125: 2049-2057, 2009.
11. Norgall S, Papoutsi M, Rossler J, Schweigerer L, Wilting J and Weich HA: Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas. BMC Cancer 7: 105, 2007.
12. Petrova TV, Makinen T, Makela TP, et al: Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 21: 4593-4599, 2002. (Pubitemid 34984346)
13. Podgrabinska S, Braun P, Velasco P, Kloos B, Pepper MS and Skobe M: Molecular characterization of lymphatic endothelial cells. Proc Natl Acad Sci USA 99: 16069-16074, 2002. (Pubitemid 35462750)
14. D'Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI and Curran T: A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374: 719-723, 1995.
15. Kohno T and Hattori M: Re-evaluation of protease activity of reelin. Biol Pharm Bull 33: 1047-1049, 2010.
16. Quattrocchi CC, Wannenes F, Persico AM, et al: Reelin is a serine protease of the extracellular matrix. J Biol Chem 277: 303-309, 2002. (Pubitemid 34952059)
17. D'Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M and Curran T: Reelin is a ligand for lipoprotein receptors. Neuron 24: 471-479, 1999. (Pubitemid 29508420)
18. Benhayon D, Magdaleno S and Curran T: Binding of purified Reelin to ApoER2 and VLDLR mediates tyrosine phosphorylation of Disabled-1. Brain Res Mol Brain Res 112: 33-45, 2003. (Pubitemid 36369244)
19. Hiesberger T, Trommsdorff M, Howell BW, et al: Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24: 481-489, 1999. (Pubitemid 29508421)
20. Howell BW, Hawkes R, Soriano P and Cooper JA: Neuronal position in the developing brain is regulated by mouse disabled-1. Nature 389: 733-737, 1997. (Pubitemid 27458960)
21. Strasser V, Fasching D, Hauser C, et al: Receptor clustering is involved in Reelin signaling. Mol Cell Biol 24: 1378-1386, 2004. (Pubitemid 38112197)
22. Trommsdorff M, Gotthardt M, Hiesberger T, et al: Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97: 689-701, 1999. (Pubitemid 29278044)
23. Dulabon L, Olson EC, Taglienti MG, et al: Reelin binds alpha-3beta1 integrin and inhibits neuronal migration. Neuron 27: 33-44, 2000.
24. Hoe HS, Lee KJ, Carney RS, et al: Interaction of reelin with amyloid precursor protein promotes neurite outgrowth. J Neurosci 29: 7459-7473, 2009.
25. Yip YP, Kronstadt-O'Brien P, Capriotti C, Cooper JA and Yip JW: Migration of sympathetic preganglionic neurons in the spinal cord is regulated by Reelin-dependent Dab1 tyrosine phosphorylation and CrkL. J Comp Neurol 502: 635-643, 2007. (Pubitemid 46732513)
26. Evangelisti C, Florian MC, Massimi I, et al: MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. FASEB J 23: 4276-4287, 2009.
27. Hughes M, Marsden HB and Palmer MK: Histologic patterns of neuroblastoma related to prognosis and clinical staging. Cancer 34: 1706-1711, 1974.
28. Peuchmaur M, d'Amore ES, Joshi VV, et al: Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer 98: 2274-2281, 2003. (Pubitemid 37392433)
29. Becker J, Wang B, Pavlakovic H, Buttler K and Wilting J: Homeobox transcription factor Prox1 in sympathetic ganglia of vertebrate embryos: correlation with human stage 4s neuroblastoma. Pediatr Res 68: 112-117, 2010.
30. Chen Y, Kundakovic M, Agis-Balboa RC, Pinna G and Grayson DR: Induction of the reelin promoter by retinoic acid is mediated by Sp1. J Neurochem 103: 650-665, 2007. (Pubitemid 47498032)
31. Pahlman S, Hoehner JC, Nanberg E, et al: Differentiation and survival influences of growth factors in human neuroblastoma. Eur J Cancer 31A: 453-458, 1995.
32. Wilting J, Papoutsi M, Christ B, et al: The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J 16: 1271-1273, 2002.
33. Lagodny J, Juttner E, Kayser G, Niemeyer CM and Rossler J: Lymphangiogenesis and its regulation in human neuroblastoma. Biochem Biophys Res Commun 352: 571-577, 2007. (Pubitemid 44838525)
34. Falconer DS and Sierts-Roth U: Dreher, a new gene of the waltzer-shaker group in the house mouse. Z Indukt Abstamm Vererbungsl 84: 71-73, 1951 (In undetermined language).
35. Fatemi SH: Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly. Mol Psychiatry 6: 129-133, 2001.
36. Hourihane JO, Bennett CP, Chaudhuri R, Robb SA and Martin ND: A sibship with a neuronal migration defect, cerebellar hypoplasia and congenital lymphedema. Neuropediatrics 24: 43-46, 1993. (Pubitemid 23202885)
37. Lorenzetto E, Panteri R, Marino R, Keller F and Buffelli M: Impaired nerve regeneration in reeler mice after peripheral nerve injury. Eur J Neurosci 27: 12-19, 2008.
38. Panteri R, Mey J, Zhelyaznik N, et al: Reelin is transiently expressed in the peripheral nerve during development and is upregulated following nerve crush. Mol Cell Neurosci 32: 133-142, 2006. (Pubitemid 43868102)
39. Smalheiser NR, Costa E, Guidotti A, et al: Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells. Proc Natl Acad Sci USA 97: 1281-1286, 2000. (Pubitemid 30080850)
40. Kim DH, Iijima H, Goto K, et al: Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J Biol Chem 271: 8373-8380, 1996.
41. Koch S, Strasser V, Hauser C, et al: A secreted soluble form of ApoE receptor 2 acts as a dominant-negative receptor and inhibits Reelin signaling. EMBO J 21: 5996-6004, 2002. (Pubitemid 35415318)
42. Brandes AA, Palmisano V, Pasetto LM, Basso U and Monfardini S: High-dose chemotherapy with bone marrow rescue for high-grade gliomas in adults. Cancer Invest 19: 41-48, 2001. (Pubitemid 32233801)
43. Brandes C, Novak S, Stockinger W, Herz J, Schneider WJ and Nimpf J: Avian and murine LR8B and human apolipoprotein E receptor 2: differentially spliced products from corresponding genes. Genomics 42: 185-191, 1997. (Pubitemid 27263747)
44. Kim DH, Magoori K, Inoue TR, et al: Exon/intron organization, chromosome localization, alternative splicing, and transcription units of the human apolipoprotein E receptor 2 gene. J Biol Chem 272: 8498-8504, 1997. (Pubitemid 27147813)
45. Bock HH, Jossin Y, Liu P, et al: Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination. J Biol Chem 278: 38772-38779, 2003. (Pubitemid 37221776)
46. Thiele C: Neuroblastoma cell lines. In: Human Cell Culture. Vol 1. Masters J (ed). Kluwer Academic Publishers, Lancaster, pp21-53, 1998.
47. Zhao S and Frotscher M: Go or stop? Divergent roles of Reelin in radial neuronal migration. Neuroscientist 16: 421-434, 2010.
48. Meyer G and Goffinet AM: Prenatal development of reelinimmunoreactive neurons in the human neocortex. J Comp Neurol 397: 29-40, 1998. (Pubitemid 28304050)
49. Senturk A, Pfennig S, Weiss A, Burk K and Acker-Palmer A: Ephrin Bs are essential components of the Reelin pathway to regulate neuronal migration. Nature 472: 356-360, 2011.
50. Schmid RS, Jo R, Shelton S, Kreidberg JA and Anton ES: Reelin, integrin and DAB1 interactions during embryonic cerebral cortical development. Cereb Cortex 15: 1632-1636, 2005. (Pubitemid 41344512)
51. Sato N, Fukushima N, Chang R, Matsubayashi H and Goggins M: Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers. Gastroenterology 130: 548-565, 2006. (Pubitemid 43202051)
52. Perrone G, Vincenzi B, Zagami M, et al: Reelin expression in human prostate cancer: a marker of tumor aggressiveness based on correlation with grade. Mod Pathol 20: 344-351, 2007. (Pubitemid 46348333)
53. Seigel GM, Hackam AS, Ganguly A, Mandell LM and Gonzalez-Fernandez F: Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis 13: 823-832, 2007. (Pubitemid 46908324)
54. Wang Q, Lu J, Yang C, et al: CASK and its target gene Reelin were co-upregulated in human esophageal carcinoma. Cancer Lett 179: 71-77, 2002. (Pubitemid 34195655)